anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
All participants will receive the MWM intervention with weight bearing ankle dorsiflexion range of motion measured prior to the intervention, immediately following the intervention, and 24 hours (+/- 3 hours) following the intervention. The participant will first place their foot on a 16-inch box to assist in performance of the intervention by the therapist. A licensed physical therapist (PT) will then stabilize the talus for a proper joint mobilization to be performed. The therapist will then mobilize the distal tib/fib in the posterior to anterior direction at end range DF reached through a forward lunge, using a Mulligan's mobilization belt around the distal tibia-fibula. The participant will perform 3 sets of 10 repetitions of the forward lunge and the PT will perform a bout of overpressure at end range during each repetition. Two other investigators will be on either side of participant to assist with balance during the intervention if needed.

Weight bearing ankle dorsiflexion range of motion will be measured via a primary and secondary measure. The primary measurement will be use of a bubble inclinometer and the secondary measurement will be the standing ankle dorsiflexion screen (SADS).
Influenza is still responsible for more than 650,000 deaths per year worldwide and no major improvements in patients' care has been made despite 50 years of research. Most of severe influenza patients suffer from acute lung injury due to a dysregulated immune response. Neutrophils are involved in both host resistance and disease tolerance. Thanks to advances in technologies, the vast variety in neutrophils subpopulations has been revealed. In particular, the subpopulation of CXCR4-expressing neutrophils has been suggested to be involved in the rupture of disease tolerance in lung infections. Nevertheless, these data are from murine models and remain to be confirmed in humans. Moreover, the underlying mechanisms remain unknown as well as the place of primum movens, i.e. vascular or alveolar compartment. The aim of this study is thus to compare the percentage of blood CXCR4-expressing neutrophils between influenza survivors and non-survivors. Percentage of BAL CXCR4-expressing neutrophils will also be compared. To this aim, blood sampling and BAL within the 24 hours and at day 3 after admission to ICU, neutrophils isolation, immunostaining and flow cytometry acquisition will be performed within the 24 hours and at day 3 after admission to ICU. Mortality rate will be collected at Day 28 and Day 90.
Smart pH-sensing microencapsulation system programmed to actively respond to environmental pH change has long been considered a key technology in pharmaceutical industries and food sciences. Maintenance of both stability of active materials in harsh gastrointestinal (GI) tract environments and release at target site-specific pH is a major obstacle in oral drug/vaccine development. In this study, we developed a first-of-its-kind drug delivery system with pH-responsive macropores. Opening and closing of these macropores depend on pH  to meet the critical requirements of intestine-targeted drug delivery system, providing stability in stomach and rapid release in intestine. To this end, we developed pored hollow microparticles (MPs) made of anionic copolymer using an Oil-in-Water (O/W) emulsion method. We observed that freeze-drying of MPs induced closure of macropores on their surface, probably due to the decrease of glass transition temperature via surfactant incorporation and/or physicochemical characteristics of polymer-water and polymer-polymer interaction during dehydration process.  The closing and opening behavior of the sealed macropore on MPs in response to pH change were confirmed after being subjected to simulated gastric pH (2-hr incubation at pH 2.0) and intestinal pH (4-hr incubation at pH 7.1), respectively. Time dependent release behavior of ingredients through pH-sensing pores was tested using two different types of model drugs (sulforhodamine b and 100 nm sized fluorescent nanoparticles). The intact, closed structure of the dye-encapsulated macropore was maintained in simulated gastric environment. Subsequent exposure of the same sample to simulated intestine environment induced pore opening, which caused release of the ingredients from MPs. To demonstrate the applicability of our microencapsulation system for active biomolecules, lactase enzymes were encapsulated in MPs.  Theses MPs displayed more than 15 times higher protections than commercial lactase formulations, indicating the protective activity of the MP system against harsh GI conditions.  This study showed that taking mutual advantages of solid and hollow architectures, microparticles with a pH-responsive macropore exhibited easy solvent-free loading and protection of ingredients in unfavorable pH by closing pores, and triggered their release in targeted pH by opening pores. Ultimately, our MP system with a pH-sensing macropore strives to usher a new area of research in smart drug delivery systems and advance the current oral drug delivery technology by solving major challenges in targeted delivery of pH-sensitive therapeutic agents.
Patients who are receiving treatment with Elaprase in this study (SHP-ELA-401), who are \<6 years of age, and were previously treatment-naïve. Patients who are not enrolled in this study (SHP-ELA-401) but are enrolled in the Hunter Outcome Survey (HOS) patient registry and were \< 6 years of age at start of Elaprase treatment. While not enrolled in the present Study SHP-ELA-401, their height and weight data from HOS will be utilized in the Primary Growth Analysis for this study.
PURPOSE: A composition containing novel bacteriophage for preventing or treating infectious diseases is provided to ensure acid resistance and thermal resistant. CONSTITUTION: A novel bacteriophage has a specific apoptotic ability to Salmonella enteritidis, Salmonella typhimurium, Salmonella gallinarum, or Salmonella pullorum. The bacteriophage belongs to morphotype B1 Siphoviridae with isometric capsid and long non-contractile tail. The bacteriophage has proteins of 40-43 kDa, 79-82 kDa, 14-16 kDa, 59-62 kDa and 41-44 kDa. The bacteriophage contains nucleic acid molecules of sequence numbers 1, 2, 3, 4, or 5. A composition for preventing or treating infectious diseases contains the bacteriophage as an active ingredient.
The invention relates to substantially dust-free bleach powders that, when mixed with aqueous hydrogen peroxide, yield activated bleach compositions that exhibit improved thixotropy. The bleach powders comprise at least one de-dusting agent and at least one peroxygenated salt. The de-dusting agents, which are preferably present in an amount less than about 10 % by weight of the bleach powder are inert, substantially hydrophilic compounds selected from alkylated esters, cyclic ethers and cyclic esters. The bleach powders also comprise powdered polytetrafluoroethylene (PTFE) in an amount of about 1-5 % by weight of the bleach powder. The bleach powders also comprise an ammonia source, e.g., an ammonium halide, diammonium phosphate, ammonium sulfate and mixtures thereof. Optionally, one or more hair conditioning agents, thickeners and desiccants may be added to the dust-free bleach powder.
Magnetic resonance spectroscopy (MRS) is commonly applied in medicine with 1H proton or 31-phosphorus spectra. The proton MRS is often used in evaluating the central nervous system and 31P MRS is used in muscular diseases or neoplasms. However, the proton MRS is also considered to be applied to the musculoskeletal system because of its profound amount of protons. Ballon used the STEAM technique, and Schick used the PRESS technique, to investigate the lipid and water spectra of the bone marrow and also correlated those with hematological diseases and post-treatment effects. Schellinger et al. used the STEAM sequence to calculate the lipid content of the vertebral bone marrow and found that it was influenced according to age and sex. The investigator had used the proton MRS to evaluate the lipid and water spectra of the femoral head and revealed its significance in predicting avascular necrosis of the femoral head. According to the above research literature, the investigators considered further investigation of the proton MRS in evaluating the musculoskeletal system.
A method and system for recognizing a medical symptom from a patient description. An exemplary artificial intelligence system includes a patient interaction interface configured to receive the patient description (103) including at least one span. The system also includes a processor (104). The processor (104) is configured to determine word vectors for words in a span and weights associated with the respective word vectors. The processor (104) is further configured to determine a weighted word vector based on the word vectors and the associated weights. The processor (104) is also configured to construct a span representation using the weighted word vector, and determine the medical symptom based on the span representation.
Post-operative pain in patients undergoing osteotomy can be severe. Current methods of treatment involve parenteral narcotics and regional anesthesia. Several studies have looked at the efficacy of regional anesthesia with various combinations of local anesthetic and additives in different populations. However, to our knowledge there have been none that directly compare bupivacaine/clonidine epidural with supplemental narcotics to parenteral narcotics alone. Many studies substantiate the efficacy of bupivacaine and clonidine as effective drugs for epidural analgesia (1,2,3). Parenteral narcotic alone is associated with the possibility of significant side effects, overdose, and inadequate analgesia. Epidural analgesia has been shown to reduce postoperative pain scores more than parenteral narcotics (4). We believe that this study is important since the protocol allows additional parenteral narcotic in the epidural group if needed, and also allows for narcotic dosing prior to discontinuation of the epidural to compensate for rebound pain. Further, the prolongation of pain control shown with epidural clonidine may be beneficial during the transition (5,6).
The disclosure describes a method and system for delivering a drug to a genitofemoral nerve or a genital branch of a genitofemoral nerve of a patient. The system includes drug delivery devices that deliver one or more drugs for alleviation of pelvic pain. The system may deliver drug therapy for pelvic pain in men or women. Drug therapy may be delivered at various locations along a single or both genitofemoral nerves and the genital branch of a single or both genitofemoral nerves of a patient via a fluid transfer device. When implanted proximate to a genital nerve branch, the fluid transfer device may be implanted proximate to the genital nerve branch. In a male patient stimulation may be delivered proximate to the spermatic cord, which contains a portion of the genital nerve branch. In some embodiments, electrical stimulation may be applied in combination with drug therapy to a genitofemoral nerve or a genital nerve branch of the genitofemoral nerve of a patient.
Spinal cord injury (SCI) results in stalled motor function recovery under the chronic phase. One of the reasons due to the presence of ongoing inflammation. Therefore, regulating the status of immune cells may help reopen the window for neural repair, which represents a potential therapeutic target. In this study, we aimed to investigate whether this could be achieved in mice with cervical 5 crush CSCI (4 W) by utilizing a concentration of 0.5 mg/kg of lipopolysaccharide (LPS) to stimulate microglia/macrophages. Additionally, the mice underwent rehabilitation training for another 6 weeks. Our results showed that systemic injection of LPS enhanced the effects of forelimb rehabilitation training, as evaluated through single pellet grasping (SPG). Electrophysiological studies revealed the restoration of cortical drive to the injured side's forelimb muscles in the training combined with LPS group. Tract tracing studies demonstrated the reconstruction of cortical innervation to the cervical spinal cord. Furthermore, the levels of pro-inflammatory phenotype markers, such as inducible nitric oxide synthase (INOS) and CD68, decreased, while the expression of anti-inflammatory phenotype markers, including arginase 1 (ARG-1) and CD206, increased. Importantly, this phenotypic switch in microglia/macrophages was accompanied by an increase in phagocytic activity markers as indicated by BODIPY + IBA1 + staining. Collectively, our data suggests that low-dose LPS improves the effects of rehabilitation training by regulating the phenotypic transformation of microglia/macrophages in CSCI. This study provides a fresh perspective and intervention direction for the clinical treatment of chronic spinal cord injuries.
PROBLEM TO BE SOLVED: To obtain a humectant having actions of improving the moisture retaining ability of a horny layer and further permeating into hair and enhancing actions on protective effects thereof by including a specific amide derivative as an active ingredient. SOLUTION: This humectant is obtained by including an amide derivative represented by formula I (R is a 5-23C alkyl or a 5-23C alkenyl) as an active- ingredient. The derivative represented by formula I can be produced by a method, etc., for condensing, e.g. a carboxylic acid represented by formula II or its reactive derivative (an acid halide, an ester, an acid anhydride or the like) with a diglycolamine represented by the formula H2N-(CH2CH2O)2-H, as necessary, in the presence of a basic catalyst, etc., at room temperature to 250 deg.C under atmospheric pressure or a reduced pressure of 0.01 mmHg while preferably removing water or an alcohol produced by the reaction. The derivative represented by formula I is useful as the humectant, a skin preparation for external use for improving skin roughening and a hair cosmetic.  Furthermore, the hair cosmetic is the one except a shampoo such as a hair rinse or a hair styling agent.
Patients will receive either regorafenib by mouth on days 1-21 every 28 day cycle or TAS-102 by mouth twice daily on days 1-5 and 8-12 every 28 day cycle as per standard of care. Patients in this arm will continue treatment in the absence of disease progression or unacceptable toxicity.
Posterior fossa type A (PF-EPN-A, PFA) ependymoma are aggressive tumors that mainly affect children and have a poor prognosis. Histopathology shows significant intratumoral heterogeneity, ranging from loose tissue to often sharply demarcated, extremely cell-dense tumor areas. To determine molecular differences in morphologically different areas and to understand their clinical significance, we analyzed 113 PF-EPN-A samples, including 40 corresponding relapse samples. Cell-dense areas ranged from 0 to 100% of the tumor area and displayed a higher proportion of proliferating tumor cells (p < 0.01). Clinically, cell density was associated with poor progression-free and overall survival (pPFS = 0.0026, pOS < 0.01). Molecularly, tumor areas with low and high cell density showed diverging DNA methylation profiles regarding their similarity to distinct previously discovered PF-EPN-A subtypes in 9/21 cases. Prognostically relevant chromosomal changes at 1q and 6q showed spatial heterogeneity within single tumors and were significantly enriched in cell-dense tumor areas as shown by single-cell RNA (scRNA)-sequencing as well as copy number profiling and fluorescence in situ hybridization (FISH) analyses of different tumor areas. Finally, spatial transcriptomics revealed cell-dense areas of different tumors to be more similar than various different areas of the same tumor. High-density areas distinctly overexpressed genes encoding histone proteins, WNT5A, TGFB1, or IGF2. Relapsing tumors displayed a higher proportion of cell-dense areas (p = 0.036), a change in PF-EPN-A methylation subtypes (13/32 patients), and novel chromosome 1q gains and 6q losses (12/32 cases) compared to corresponding primary tumors. Our data suggest that PF-EPN-A ependymomas habor a previously unrecognized intratumoral heterogeneity with clinical implications, which has to be accounted for when selecting diagnostic material, inter alia, by histological evaluation of the proportion of cell-dense areas.
The purpose of the TCU DRR2 project is to adapt ideas and concepts from an in-prison, group-based curriculum designed to improved decision-making skills around health risk behaviors for incarcerated offenders in the last phase of substance abuse treatment for a self-administered computer app that targets probationers under community supervision. Programming for HIV in probation settings is limited and this project aims to address needs with an easy to use computer app that is designed to improve decision-making about health risks among probationers in the community. The computer app utilizes an evidence-based schema called WORKIT and is based on a dual processing model of judgment and decision-making that includes vicarious and virtual learning approaches and repetition in order to learn and practice the schema and move it from slower analytical processing to faster experiential processing.

StaySafe includes 12 brief sessions, each of which takes about 10 minutes to complete. Nine of the sessions utilize the WORKIT model and three session use a participant choice activity in which probationers can choose from among several informational activities designed to reinforce lessons learned and provide some variation to completing WORKIT sessions. The first session includes an introduction to using the app on the tablet and guides the participant through a WORKIT session. In each subsequent WORKIT session, the participant chooses a relevant problem to work on during that session from a list of problems. A brief video is then shown in which two people are having a conversation around the problem and make a decision. The participant rates the decision before working through the WORKIT process around the chosen problem. This involves determining what the problem is, who is affected by the problem and who can help with the problem, then identifying options to address the problem, rating the options, knowing what option to choose, imagining the steps to carry out the option, and then testing the results. Sessions are typically scheduled about every two weeks.

Participants are recruited by research staff for the study from probation offices where substance abuse groups are conducted. All assessment and StaySafe sessions are administered by research staff at the probation facility when probationers otherwise report for meetings or groups. Compensation for time involved in the study is provided in terms of payments toward probation fees. After an Institutional Review Board (IRB)-approved consent procedure, participants are scheduled for a baseline survey that takes about 30 minutes to complete. After the baseline survey is completed, participants are randomly assigned to either the StaySafe condition or a comparison condition. Participants in the StaySafe condition are then scheduled for their first StaySafe session typically within a week and are asked to complete twelve sessions within the next 6 months, followed by 6-month and 12-month follow-up surveys. Participants randomly assigned to a comparison condition are informed that they will be contacted in about 6 months to schedule a 6-month survey and again for a 12-month survey.
"A chronic, diffuse abnormality of the meibomian glands, frequently characterized by terminal duct obstruction and/or qualitative/quantitative abnormalities in glandular secretion," is how the International Workshop on meibomian gland (MG) hypofunction or dysfunction (MGD) describes MGD. These glands, which are repurposed sebaceous glands, secrete meibum onto the ocular surface. By improving the quality and quantity of meibum secretion, signs and symptoms of evaporative dry eye (EDE) and MGD can be alleviated.

Traditional remedies derived from natural sources have been utilized for treating anterior eye ailments since ancient times, predating the advent of contemporary pharmacological interventions. These remedies continue to be employed in diverse populations globally. The objective of this study is to examine the present non-pharmacological modalities that have been implemented and evaluate their efficacy. This encompasses alternative medicine, extant non-pharmaceutical therapeutic modalities, as well as contemporary low and high technological interventions. The most common approaches to relieving MGD involve the application of heat to the eyelids with and without physical massage of the eyelids in order to express the MGs.
This study assessed the knowledge of 12- to 15-year-old male junior high school students of HPV and HPV vaccines and their willingness to be vaccinated against it. From March to May 2023, students from six junior high schools in Zhejiang Province were randomly selected to complete an online, anonymous, self-administered questionnaire. Of the 1786 students, 618 (34.6%) reported knowledge of HPV vaccine. In general, junior high school boys have low general knowledge about HPV, the consequences of HPV infection, and the effects of HPV vaccination. Multivariate analysis showed that the subgroup scoring 6-7 on the measure of the consequences of HPV infection(7 questions with 1 score for each correct answer) compared to the subgroup scoring 0, the subgroups scoring 2 and 3 on the measure of the preventive effect of HPV vaccine(3 questions with 1 score for each correct answer) compared to the subgroup scoring 0 were were more likely to be willing to be vaccinated against HPV. Hearing that someone close to them had cancer, believing that men also need to be vaccinated against HPV, knowing that someone close to them had been vaccinated against HPV, and being concerned about cervical cancer in their female sexual partners were all more likely to generate positive responses. HPV vaccine education for this group of students should emphasize the possibility and consequences of HPV infection in males, along with the importance and benefits of HPV vaccination; actual cases of vaccination in students around them can be used to achieve this goal.
PURPOSE:To provide an antiviral extract composed of a hot-water extract of spirulina which is a kind of alga. CONSTITUTION:Body of spirulina is suspended in distilled water and heated at 70-100 deg.C for 10-120min. The extracted liquid is separated into the algal cell and liquid by centrifugal separation or filtration and the liquid is concentrated and optionally dried to obtain the objective extract. Since the hot-water extract of spirulina has remarkable antiviral activity, an antiviral pharmaceutical preparation, food additive, food and drink, especially a functional food having antiviral activity can be prepared by using the extract as an active component. Spirulina is an alga belonging to genus Spirulina. It has been used as a food and drink and confirmed to be safe. It is useful for preventing viral infection and inhibiting the spreading of the infected region.
Participants will receive milvexian capsule once daily (qd) for 5 days (Treatment A) in Period 1 followed by Atorvastatin tablets qd for 5 days (Treatment B) in Period 2 followed by milvexian capsules qd and atorvastatin tablets qd for 5 days (Treatment C) in Period 3. Each period is separated by a washout period of 7 days.